LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,592 | 54,168 | 3,925 | 5,922 | 8,666 |
| TOTAL | $50,257 | $54,321 | $4,073 | $6,078 | $8,709 |
| Non-Current Assets | |||||
| PPE Net | 279 | 114 | 89 | 51 | 38 |
| TOTAL | $279 | $114 | $89 | $51 | $38 |
| Total Assets | $50,536 | $54,435 | $4,162 | $6,129 | $8,747 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 730 | 683 | 917 | 562 | 834 |
| Accrued Expenses | 1,350 | 932 | 152 | 344 | 260 |
| TOTAL | $2,080 | $1,615 | $1,069 | $906 | $1,094 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,080 | $1,615 | $1,069 | $906 | $1,094 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,243 | 15,226 | 15,233 | 7,867 | 7,257 |
| Common Shares | 2 | 4 | 4 | 4 | 4 |
| Retained earnings | -486,614 | -479,765 | -474,713 | -470,429 | -465,301 |
| Other shareholders' equity | 6,715 | 6,715 | 6,715 | 8,459 | 10,266 |
| TOTAL | $48,456 | $52,820 | $3,093 | $5,223 | $7,653 |
| Total Liabilities And Equity | $50,536 | $54,435 | $4,162 | $6,129 | $8,747 |